Case report. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)

By Itskovitz-Eldor J  

Human Reproduction, Vol. 13, Iss. 2, 1998-02 ,pp. : 294-295

Oxford University Press

Access to resources Recommend Favorite

Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone

By Weissman A  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3421-3424

Oxford University Press

Access to resources Recommend Favorite

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

By Ben-Arie A.   Weissman A.   Shoham Z.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1146-1148

Oxford University Press

Access to resources Recommend Favorite

Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF

By Janssens RMJ   Vermeiden JPW   Lambalk CB   Schats R   Schoemaker J  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2386-2391

Oxford University Press

Access to resources Recommend Favorite

Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation

By Tiboni Gian Mario   Palumbo Paola   Leonzio Emiliana   Gabriele Elisabetta   Verna Ilde   Giampietro Franca  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite